Gout and HyperuricemiaLife Extension Suggestions
Alvarez-Lario B, Macarrón-Vicente J. Is there anything good in uric acid? QJM. 2011.
Andreadou E, Nikolaou C, Gournaras F, Rentzos M, Boufidou F, Tsoutsou A, et al. Serum uric acid levels in pa- tients with Parkinson's disease: their relationship to treatment and disease duration. ClinNeurolNeurosurg 2009; 111:724–8.
Auinger P, Kieburtz K, McDermott MP. The relationship between uric acid levels and Huntington's disease progression. MovDisord 2010; 25:224–8.
Bates CJ, Walmsley CM, Prentice A, Finch S. Does vitamin C reduce blood pressure?Results of a large study of people aged 65 or older. J. Hypertens. 1998 Jul;16(7):925.
Becker MA, Schumacher HR, Wortmann RL, et al. Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N Engl J Med. 2005;353(23):2450–2461.
Belcaro G, Cesarone MR, Dugall M, et al. Efficacy and safety of Meriva®, a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients. Altern Med Rev. 2010;15(4):337–344.
Bierer DW, Quebbemann AJ.Effect of L-dopa on renal handling of uric acid.J PharmacolExpTher. 1982;223(1):55–59.
Blau LW. Cherry diet control for gout and arthritis. Tex Rep BiolMed . 1950;8(3):309-11.
Block G, Jensen CD, Norkus EP, Hudes M, Crawford PB. Vitamin C in plasma is inversely related to blood pressure and change in blood pressure during the previous year in young Black and White women. Nutr J 2008;7:35.
Brown L, Rosner B, Willett WW, Sacks FM. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J ClinNutr 1999 Jan.;69(1):30-42.
Busso N, So A. Mechanisms of inflammation in gout.Arthritis Res. Ther. 2010;12(2):206.
Campion EW, Glynn RJ, DeLabry LO.Asymptomatic hyper- uricemia.Risk and consequences in the Normative Aging Study.Am J Med 1987; 82:421–6.
Caspi D, Lubart E, Graff E, et al. The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients.Arthritis Rheum. 2000;43(1):103–108.
Chen L, Yin H, Lan Z, et al. Anti-hyperuricemic and nephroprotective effects of Smilax china L. J Ethnopharmacol. 2011;135(2):399–405.
Chhana A, Callon KE, Pool B, et al. Monosodium urate monohydrate crystals inhibit osteoblast viability and function: implications for development of bone erosion in gout. Ann. Rheum. Dis. 2011;70(9):1684–1691.
Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Alcohol intake and risk of incident gout in men: a prospective study. Lancet. 2004b;363(9417):1277–1281.
Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med. 2004a;350(11):1093–1103.
Choi HK, Curhan G. Beer, liquor, wine, and serum uric acid level: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 2004; 51:1023 – 1029.
Choi HK, Curhan G. Coffee consumption and risk of incident gout in women: the Nurses' Health Study. American Journal of Clinical Nutrition. 2010a;92(4):922–927.
Choi HK, De Vera MA, Krishnan E. Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile. Rheumatology (Oxford). 2008a;47(10):1567–1570.
Choi HK, Ford ES.Prevalence of the metabolic syndrome in individuals with hyperuricemia.Am J Med 2007a; 120:442–7.
Choi HK, Mount DB, Reginato AM, American College of Physicians, American Physiological Society. Pathogenesis of gout. Ann Intern Med. 2005;143(7):499–516.
Choi HK, Willett W, Curhan G. Coffee consumption and risk of incident gout in men: a prospective study. Arthritis Rheum. 2007b;56(6):2049–2055.
Choi HK. A prescription for lifestyle change in patients with hyperuricemia and gout.CurrOpinRheumatol. 2010b;22(2):165–172.
Choi JWJ, Ford ES, Gao X, Choi HK. Sugar-sweetened soft drinks, diet soft drinks, and serum uric acid level: the Third National Health and Nutrition Examination Survey. Arthritis Rheum. 2008b;59(1):109–116.
Cock IE. The medicinal properties and phytochemistry of plants of the genus Terminalia (Combretaceae). Inflammopharmacol.Oct 2015;23(5):203-229.
Dao HH, Harun-Or-Rashid M, Sakamoto J. Body compos- ition and metabolic syndrome in patients with primary gout in Vietnam. Rheumatology 2010; 49:2400–7.
De Miguel E, Puig JG, Castillo C, et al. Diagnosis of gout in patients with asymptomatic hyperuricaemia: a pilot ultrasound study. Ann. Rheum. Dis. 2011.
Di Giovine FS, Malawista SE, Nuki G, Duff GW: Interleukin 1 (IL 1) as a mediator of crystal arthritis. Stimulation of T cell and synovial fibroblast mitogenesis by urate crystal-induced IL 1. J Immunol. 1987;138:3213–3218.
Dinarello CA. Blocking interleukin-1β in acute and chronic autoinflammatory diseases.Journal of Internal Medicine. 2010;269(1):16–28.
Doherty M. New insights into the epidemiology of gout.Rheumatology (Oxford). 2009;48Suppl 2:ii2–ii8.
Ea HK et al. Pegloticase and chronic gout.JAMA. 2011 Nov 9;306(18):1979; author reply 1979-80.
Eggebeen AT. Gout: an update. Am Fam Physician. 2007;76(6):801–808.
Ekundayo OJ, Dell'Italia LJ, Sanders PW, et al. Association between hyperuricemia and incident heart failure among older adults: a propensity-matched study. Int. J. Cardiol. 2010;142(3):279–287.
Enomoto, A. et al. Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 2002;417, 447–452.
Fam AG. Gout: excess calories, purines, and alcohol intake and beyond. Response to a urate-lowering diet. J Rheumatol . 2005 May;32(5):773-7.
Farah A et al. Chlorogenic acids from green coffee extract are highly bioavailable in humans. J Nutr. 2008 Dec;138(12):2309-15.
FDA. FDA approves new drug for gout. FDA NEWS RELEASE. Sept. 14, 2010. Available at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2010/ucm225810.htm Accessed 11/11/2011.
Feig DI, Soletsky B, Johnson RJ. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA. 2008;300(8):924–932.
Feigelson P. The inhibition of xanthine oxidase in vitro by trace amounts of I-ascorbic acid. J BiolChem 1952;197:843–50.
Flemmig J et al. Oleaeuropaea leaf (Ph.Eur.) extract as well as several of its isolated phenolics inhibit the gout-related enzyme xanthine oxidase. Phytomedicine. 2011 May 15;18(7):561-6. Epub 2010 Dec 8.
Ford TC (1992) Surgical management of chronic tophaceous gout. A case report. J Am Podiatr Med Assoc 82(10):514–519.
Gibson T, Rodgers AV, Simmonds HA, Toseland P. Beer drinking and its effect on uric acid. Br J Rheumatol 1984; 23: 203–09.
Glantzounis GK, Tsimoyiannis EC, Kappas AM, et al. Uric acid and oxidative stress. Curr Pharm Des. 2005;11(32):4145-51.
Grayson PC, Kim SY, LaValley M, Choi HK. Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res. 2011;63(1):102–110.
Hediger, M. A. New view at C. Nature Med. 8, 445–446 (2002).
Hu QH, Wang C, Li JM, Zhang DM, Kong LD. Allopurinol, rutin, and quercetin attenuate hyperuricemia and renal dysfunction in rats induced by fructose intake: renal organic ion transporter involvement. AJP: Renal Physiology. 2009;297(4):F1080–F1091.
Huang H-Y, Appel LJ, Choi MJ, et al. The effects of vitamin C supplementation on serum concentrations of uric acid: Results of a randomized controlled trial. Arthritis Rheum. 2005;52(6):1843–1847.
Jacob RA, Spinozzi GM, Simon VA, et al. Consumption of cherries lowers plasma urate in healthy women. J Nutr. 2003;133(6):1826–1829.
Jancin B. Cherry Juice Flowing in Gout Treatment Pipeline.Family Practice News. 2010.
Johnson RJ, Kivlighn SD, Kim YG, Suga S, Fogo AB. Reappraisal of the pathogenesis and consequences of hyper- uricemia in hypertension, cardiovascular disease, and renal disease. Am J Kidney Dis 1999; 33:225–34.
Juraschek SP, Miller ER III, Gelber AC. Effect of oral vitamin C supplementation on serum uric acid: A meta-analysis of randomized controlled trials. Arthritis Care Res. 2011;63(9):1295–1306.
Kasper DL Braunwald DE et al. Harrison's Principles of Internal Medicine . 16th ed. New York , NY : McGraw-Hill Professional; 2005.
Keizman D, Ish-Shalom M, Berliner S, Maimon N, Vered Y, Artamonov I, et al. Low uric acid levels in serum of patients with ALS: further evidence for oxidative stress? J NeurolSci 2009; 285:95–9.
Kela U, Vijayvargiya R, Trivedi CP. Inhibitory effects of methyl-xanthines on the activity of xanthine oxidase. Life Sci 1980;27:2109–19.
Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and risk of stroke: a systematic review and meta-analysis. Arthritis Rheum 2009; 61:885–92.
Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and coronary heart disease: a sys- tematic review and meta-analysis. Arthritis Care Res 2010; 62:170–80.
Kim TS, Pae CU, Yoon SJ, Jang WY, Lee NJ, Kim JJ, et al. Decreased plasma antioxidants in patients with Alzheimer's disease. Int J Geriatr Psychiatry 2006; 21:344–8.
Koguchi T, Koguchi H, Nakajima H, Takano S, Yamamoto Y, Innami S, Maekawa A, Tadokoro T: Dietary fiber suppresses elevation of uric acid and urea nitrogen concentrations in serum of rats with renal dysfunction induced by dietary adenine. Int J VitamNutr Res 2004, 74(4):253-263.
Kong LD, Cai Y et al. Inhibition of xanthine oxidase by some Chinese medicinal plants used to treat gout. J Ethnopharmacol . 2000 Nov;73(1-2):199-207.
Kramer HM, Curhan G. The association between gout and nephrolithiasis: the National Health and Nutrition Examination Survey III, 1988–1994. Am J Kidney Dis 2002;40:37–42.
Kumar V, Ajeesh R, Vidyasagaran K, Chourasia S. Evaluation of pulp content and physical characters of Thriphala in Western Ghats, India. Environment and Ecology. 2014;33(4):1454-1459.
Larmon WA (1970) Surgical management of tophaceous gout. ClinOrthopRelat Res 71:56–69.
Li Y et al. Virtual and In vitro bioassay screening of phytochemical inhibitors from flavonoids and isoflavones against Xanthine oxidase and Cyclooxygenase-2 for gout treatment.ChemBiol Drug Des.2011 Oct 3.doi: 10.1111/j.1747-0285.2011.01248.x. [Epub ahead of print]
Lin C-M, Chen C-S, Chen C-T, Liang Y-C, Lin J-K.Molecular modeling of flavonoids that inhibits xanthine oxidase.BiochemBiophys Res Commun. 2002;294(1):167–172.
Lyu L-C, Hsu C-Y, Yeh C-Y, et al. A case-control study of the association of diet and obesity with gout in Taiwan.Am J ClinNutr. 2003;78(4):690–701.
Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006;440:237–41.
Mascitelli L, Goldstein MR. Does inhibition of iron absorption by coffee reduce the risk of gout? Int. J. Clin. Pract. 2011;65(6):713.
Mazzali M, Kanbay M, Segal MS, Shafiu M, Jalal D, Feig D, et al. Uric acid and hypertension: cause or effect? CurrRheumatol Rep 2010; 12:108–17.
Mo S-F, Zhou F, Lv Y-Z, et al. Hypouricemic action of selected flavonoids in mice: structure-activity relationships. Biol. Pharm. Bull. 2007;30(8):1551–1556.
Moon D-O, Kim M-O, Choi YH, Park Y-M, Kim G-Y.Curcumin attenuates inflammatory response in IL-1β-induced human synovial fibroblasts and collagen-induced arthritis in mouse model. International Immunopharmacology. 2010;10(5):605–610.
Motamarri S, Karthikeyan M, Kannan M, Rajasekar S. Terminalia belerica Roxb.—A phytopharmacological review. Int J Res Pharma.2012;3:96-99.
Pak CY, Moe OW, Sakhaee K, Peterson RD, Poindexter JR. Physicochemical metabolic characteristics for calcium oxal- ate stone formation in patients with gouty diathesis. J Urol 2005; 173:1606–9.
Pascual E. Persistence of monosodium urate crystals and low-grade inflammation in the synovial fluid of patients with untreated gout.Arthritis Rheum 1991; 34:141–5.
Pauff JM, Hille R. Inhibition Studies of Bovine Xanthine Oxidase by Luteolin, Silibinin, Quercetin, and Curcumin. J. Nat. Prod. 2009;72(4):725–731.
Puig JG, de Miguel E, Castillo MC, Rocha AL, Martinez MA, Torres RJ. Asymptomatic hyperuricemia: impact of ultrasonography. Nucleosides Nucleotides Nucleic Acids 2008;27:592–5.
Puig JG, Fox IH. Ethanol-induced activation of adenine nucleotide turnover.Evidence for a role of acetate. J Clin Invest 1984; 74: 936–41.
Rentzos M, Nikolaou C, Anagnostouli M, Rombos A, Tsakanikas K, Economou M, et al. Serum uric acid and mul- tiple sclerosis. ClinNeurolNeurosurg 2006; 108:527–31.
Richette P, Bardin T. Gout. Lancet 2010; 375:318–28.
Roch-Ramel, F. & Guisan, B. News Physiol. Sci. 14, 80–84 (1999).
Romero-Gonzalez RR et al. Salting-out gradients in centrifugal partition chromatography for the isolation of chlorogenic acids from green coffee beans. J Chromatogr A. 2009 May 8;1216(19):4245-51. Epub 2009 Feb 10.
Salazar-Martinez E, Willett WC, Ascherio A, Manson JE, Leitz- mann MF, Stampfer MJ, et al. Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med 2004;140:1–8.
Schlesinger N, Norquist JM, Watson DJ. Serum Urate During Acute Gout. The Journal of Rheumatology. 2009;36(6):1287–1289.
Schumacher HR. The pathogenesis of gout.Cleve Clin J Med. 2008;75Suppl 5:S2–4.
Scott JT. Drug-induced gout. Baillieres Clin Rheumatol. 1991 Apr;5(1):39-60.
Shakibaei M, Csaki C, Nebrichi S, Mobasheri A. Resveratrol suppresses interleukin-1β-induced inflammatory signaling and apoptosis in human articular chondrocytes: Potential for use as a novel nutraceutical for the treatment of osteoarthritis. Biochem.Pharmacol. 2008;76(11):1426–1439.
Singh JA, Reddy SG, Kundukulam J. Risk factors for gout and prevention: a systematic review of the literature. CurrOpinRheumatol.2011:1.
Streppel MT, Arends LR, van t Veer P, Grobbee DE, Geleijnse JM. Dietary fiber and blood pressure: a meta-analysis of randomized placebo-controlled trials. Arch Intern Med 2005 Jan.;165(2):150–156.
Sun SZ, Flickinger BD, Williamson-Hughes PS, Empie MW. Lack of association between dietary fructose and hyperuricemia risk in adults.NutrMetab. 2010;7(1):16.
Sundy JS et al. Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials. JAMA. 2011 Aug 17;306(7):711-20.
Tate GA, Mandell BF, Karmali RA, et al. Suppression of monosodium urate crystal-induced acute inflammation by diets enriched with gamma-linolenic acid and eicosapentaenoic acid. Arthritis Rheum. 1988;31(12):1543–1551.
Usharani P, Nutalapati C, Pokuri VK, Kumar CU, Taduri G. A randomized, double-blind, placebo-, and positive-controlled clinical pilot study to evaluate the efficacy and tolerability of standardized aqueous extracts of Terminalia chebula and Terminalia bellerica in subjects with hyperuricemia. Clinical pharmacology: advances and applications. 2016;8:51-59.
Vandenberg MK, Moxley G, Breitbach SA, Roberts WN. Gout attacks in chronic alcoholics occur at lower serum urate levels than in nonalcoholics. J Rheumatol 1994; 21: 700–04.
Wang Y, Zhu JX et al. Administration of procyanidins from grape seeds reduces serum uric acid levels and decreases hepatic xanthine dehydrogenase/oxidase activities in oxonate-treated mice. Basic ClinPharmacolToxicol. 2004 May;94(5):232-7.
Wann AK, Mistry J, Blain EJ, Michael-Titus AT, Knight MM. Eicosapentaenoic acid and docosahexaenoic acid reduce interleukin-1β-mediated cartilage degradation. Arthritis Res. Ther. 2010;12(6):R207.
Whelton SP, Hyre AD, Pedersen B, Yi Y, Whelton PK, He J. Effect of dietary fiber intake on blood pressure: a meta-analysis of randomized, controlled clinical trials. J. Hypertens. 2005 Mar.;23(3):475–481.
Yan H, Ma Y, Liu M, Zhou L. The Dual Actions of PaederiascandensExtract as a Hypouricemic Agent: Xanthine Oxidase Inhibitory Activity and Uricosuric Effect. Planta Med. 2008;74(11):1345–1350.
Zhang W, Doherty M, Bardin T, et al. EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT). Ann. Rheum. Dis. 2006b;65(10):1312–1324.
Zhang W, Doherty M, Pascual E et al. EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2006a;65:1301–11.
Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum. 2011;63(10):3136–3141.